Combination strategies incorporating oncolytic viruses and immune checkpoint inhibitors for advanced melanoma: what is the evidence?

Ann Transl Med. 2023 Aug 30;11(10):369. doi: 10.21037/atm-2023-5. Epub 2023 Mar 17.

Authors

Amarin Wongariyapak¹, Victoria Roulstone¹, Alan A Melcher², Malin Pedersen^{1

2}, Kevin J Harrington¹

Affiliations

¹ Targeted Therapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.
² Translational Immunotherapy Team, Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, UK.

No abstract available

Keywords: Advanced melanoma; immune checkpoint inhibition (ICI); oncolytic virus (OV); pembrolizumab; talimogene laherparepvec (T-VEC).

Publication types

Editorial
Comment